Hayashibara Brings Back “Trehalose Symposium” to Reveal Its Game-changing Versatilities in Human Biochemistry
OKAYAMA, Japan, Oct. 4, 2022 /PRNewswire/ -- Hayashibara Co., Ltd., a member of Nagase Group and headquartered in Okayama City, western Japan, hosted the 24th Trehalose Symposium, with the support of the Japanese Society of Applied Glycoscience, on September 8, 2022. Photo: https://kyodonewsprwire.jp/prwfile/release/M104815/202209297422/_prw_PI1fl_JX2ftzQv.png This highly specialized academic event returned to Tokyo after a three-year hiatus, engaging 231 attendees...
4 in 5 Asia Pacific Consumers Have Experienced Effects of Climate Change and Recognize the Importance of Environmental Sustainability When Making Nutrition-Related Decisions – Herbalife Nutrition Survey
Herbalife Nutrition launches its Asia Pacific Simply Recycle Challenge to encourage collective action against climate change SYDNEY, Oct. 4, 2022 /PRNewswire/ -- Premier global nutrition company, Herbalife Nutrition, today released findings from its Asia Pacific Nutrition Sustainability Survey, which revealed that the vast majority – four in five – of consumers in Asia Pacific said that they have experienced the...
Duality announced the appointment of Dr. Yver as Chairman of SAB
PRINCETON, N. J. and SHANGHAI, SUZHOU, China, Oct. 3, 2022 /PRNewswire/ -- Duality Biotherapeutics, Inc. ("Duality" or "the Company") today announced the appointment of Dr. Antoine Yver as Chairman of SAB. Dr. Antoine Yver will provide strategic advice and guidance for the Company's R&D and pipeline development to elevate the Company's innovation in the field of Antibody Drug Conjugates (the "ADC"), and...
DetectedX to Provide Free Access to Radiology Online Learning Platform to Radiology Across Borders to Enhance Global Charity’s Teaching Initiatives
Radiology Across Borders will Promote Access to DetectedX's On-Demand, Web-Based Educational Platform to Clinicians from Developing Nations to Improve Diagnostic Accuracy SYDNEY, Oct. 3, 2022 /PRNewswire/ -- DetectedX announced today that it will provide free access to its Radiology Online Learning Centre to Radiology Across Borders (RAB) to enhance the global charity's...
Estrella Biopharma, Inc., a biopharmaceutical company to Become a Publicly Traded Company Via Merger with TradeUP Acquisition Corp.
NEW YORK, Oct. 3, 2022 /PRNewswire/ -- Estrella Biopharma, Inc. ("Estrella"), a preclinical-stage biopharmaceutical company focusing on cancer therapeutics, and TradeUP Acquisition Corp. ("TradeUP") (NASDAQ: UPTD), a publicly traded special purpose acquisition company, today announced that they have entered into a definitive business combination agreement on September 30, 2022 that will result in Estrella becoming a publicly listed...
Kira Pharmaceuticals Receives FDA Clearance of IND Application for Phase 2 Evaluation of KP104 in Systemic Lupus Erythematosus Associated Thrombotic Microangiopathy (SLE-TMA)
Phase 1 supporting data indicated an encouraging profile and confirmed the dual mechanism of action achieved through targeting both the alternative and terminal complement pathways CAMBRIDGE, Mass., Oct. 3, 2022 /PRNewswire/ -- Kira Pharmaceuticals, a global biotechnology company pioneering transformational complement therapies to treat immune-mediated diseases, announced today that the US Food...
DEBIOPHARM REINFORCES THE BOND BETWEEN SWISS AND JAPANESE CANCER RESEARCH WITH THE 2022 JCA MAUVERNAY AWARD CEREMONY
Debiopharm awards the winning scientists for the JCA (Japanese Cancer Association) Award for innovative, disruptive, and translational oncology research LAUSANNE, Switzerland, Oct. 3, 2022 /PRNewswire/ -- Debiopharm (www.debiopharm.com), a Swiss-based global biopharmaceutical company, today announced the two winners of JCA Mauvernay Award for breakthrough Japanese oncology research projects in 2 categories: Innovative and/or Disruptive Research – Dr. Akihide Yoshimi and for...
AXA Launches “MediEnhancer Supplement”
Offers Up to 4% p.a. Guaranteed Returns Helping Customers To Cope With Medical Inflation HONG KONG, Oct. 3, 2022 /PRNewswire/ -- AXA Hong Kong and Macau (AXA) today announced the launch of "MediEnhancer Supplement" ("MediEnhancer"). "MediEnhancer" is offered exclusively to customers with qualified AXA medical insurance policies. With its up to 4% p.a. guaranteed crediting interest rate, it carries a cash...
AeroRx Partners with HCmed to Develop a Nebulized LABA/LAMA Combination Solution for the Treatment of Chronic Obstructive Pulmonary Disease
TAIPEI, Oct. 3, 2022 /PRNewswire/ -- AeroRx Therapeutics, LLC. (AeroRx) and HCmed Innovations Co., Ltd. (HCmed) have initiated a collaboration, introducing a LABA/LAMA combination solution for delivery with a breath-actuated nebulizer. This collaboration sets forth the framework by which both companies will work together to develop a new nebulized combination formulation for the treatment of chronic obstructive pulmonary...
Qilian International Holding Group Limited Reports Financial Results for the First Six Months of Fiscal Year 2022
JIUQUAN, China, Sept. 30, 2022 /PRNewswire/ -- Qilian International Holding Group Limited (Nasdaq: QLI) (the "Company"), a China-based pharmaceutical and chemical products manufacturer, today announced its unaudited financial results for the first six months of fiscal year 2022 ended March 31, 2022. Mr. Zhanchang Xin, Chairman and CEO of the Company, commented, "Under the impact of uncertain political climate...
